Wednesday, 20 July 2016

Finally, Attention Switches To Progressive Multiple Sclerosis.

Source Managed Care Mag.

A surge of new MS treatments have been for the relapsing-remitting form of the disease. A new drug that targets CD20-positive B cells may change that.  Read on.